Cart
sales@molnova.com
IN-1233
CAS No. 1093952-95-4
IN-1233( IN1233 | IN 1233 )
Catalog No. M10361 CAS No. 1093952-95-4
A potent and selective TGF-βRI (ALK5) inhibitor with IC50 of 34 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameIN-1233
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent and selective TGF-βRI (ALK5) inhibitor with IC50 of 34 nM.
-
DescriptionA potent and selective TGF-βRI (ALK5) inhibitor with IC50 of 34 nM, prevents tissue hyperplasia in the rat urethra or common iliac artery.
-
In Vitro——
-
In Vivo——
-
SynonymsIN1233 | IN 1233
-
PathwayTGF-beta/Smad
-
TargetTGFBR
-
RecptorTGFBR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1093952-95-4
-
Formula Weight419.488
-
Molecular FormulaC26H21N5O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name3-((4-(6-methylpyridin-2-yl)-5-(quinolin-6-yl)-1H-imidazol-2-yl)methyl)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kim JH, et al. Radiology, May 2013 Volume 267, Issue 2, doi.org/10.1148/radiol.121203612. Kim JH, et al. Radiology. 2010 Apr;255(1):75-82.
molnova catalog
related products
-
LDN-214117
A potent and selective ALK2 inhibitor with a biochemical IC50 of 24 nM, a cell-based IC50 for BMP6 of 100 nM.
-
SRI-011381 hydrochlo...
SRI-011381, a new-type agonist of the TGF-beta signaling pathway, is utilized in the treatment of Alzheimer's disease.
-
A77-01
A potent inhibitor of TGF-β type I receptor superfamily activin-like kinase ALK5 with IC50 of 25 nM.
